Labcorp Holdings Inc.

NYSE:LH

Medical - Diagnostics & Research

Healthcare
$370.78 -1.33%

-$3.46 today

Market cap
$30.11B
Beta
0.88
P/E (TTM)
22.4
EPS (TTM)
$11.44
Dividend yield
1.12%
52W Low $241.81High $293.72

Volume 0.69M

Average 0.63M

LH Total Non-current Liabilities

All obligations due after more than one year.

Labcorp Holdings Inc.NYSE: LH

Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026

Total non-current liabilities rises 13.6% from a year ago

Total non-current liabilities stood at $7.78B at the end of Q2 FY2026, up 13.6% from a year earlier and up 1.1% from the prior quarter. Over 3 fiscal years it compounded at -0.1% a year.

Context

  • Total non-current liabilities amounted to 42.0% of total assets at the end of Q2 FY2026, up 4.1 pp from a year earlier.
  • Total non-current liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +13.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$7.78B+1.1% QoQ
Last fiscal yearDec 2025
$6.93B-0.7% YoY
Year agoJun 2025
$6.85B+13.6% since
Total Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.6%——
1 year-0.7%——
3-year CAGR-0.1%——
5-year CAGR——
10-year CAGR——

Total Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
6.93B USD
Year-over-year change
-0.7%
4-year CAGR
-1.3%

Total Non-current Liabilities vs competitors

How LH compares with its peers on the latest reported figures

  • LH's Jun 2026 total non-current liabilities of $7.78B is the 2nd highest of the 7 companies compared; the peer median is $1.87B.
  • Its year-over-year change of +13.6% is the 5th highest of 7, against a peer median of +25.4%.
  • Total non-current liabilities amounts to 42.0% of total assets for LH, versus a peer median of 36.4%.
LH Competitors Peer median
Total Non-current Liabilities for LH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$45.3B +22.5%+5.0%39.7%
LHLabcorp Holdings Inc.Jun 2026$7.78B +13.6%-0.1%42.0%
DGXQuest Diagnostics IncorporatedSep 2026$7.36B +10.0%+8.1%42.7%
QGENQiagen N.V.Jun 2026$1.95B +63.9%+2.8%33.1%
GHGuardant Health, Inc.Sep 2026$1.79B +28.3%+10.1%94.8%
NTRANatera, Inc.Jun 2026$282.8M +124.4%-2.1%10.6%
GRALGRAIL, Inc.Jun 2026$217.49M -31.4%-31.4%7.6%
Peer median (excluding LH) $1.87B+25.4%+3.9%36.4%

Competitors are the stored peer set for LH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.47B320.6M536.8M1.52B532.3M
Short-term Investments00000
Net Receivables2.98B2B2.1B2.1B2.26B
Inventory401.4M470.6M474.6M493.2M534.7M
Other Current Assets01.84B655.3M697.6M1
Total Current Assets5.33B4.63B3.77B4.81B4.02B
Property, Plant & Equipment (Net)2.82B2.79B2.91B3.05B3.08B
Goodwill7.96B6.12B6.14B6.37B6.79B
Intangible Assets3.74B3.12B3.34B3.49B3.6B
Long-term Investments60.9M65.7M26.9M16.3M153.9M
Tax Assets21.6M6.4M000
Other Non-current Assets462.6M3.42B536.5M652.2M751.3M
Total Non-current Assets15.05B15.53B12.96B13.57B14.37B
Total Assets20.39B20.16B16.73B18.38B18.39B
Account Payables621.3M852.2M827.5M875.8M840.8M
Short-term Debt1.5M301.3M999.8M1B695.8M
Tax Payables239.6M146.1M127.5M152.7M0
Deferred Revenue558.5M310.6M421.7M392.2M439.1M
Other Current Liabilities735.5M1.1B431.4M495.4M847.8M
Total Current Liabilities2.78B3.08B3.23B3.33B2.82B
Long-term Debt5.42B5.04B4.05B5.33B5.77B
Deferred Tax Liabilities762.9M543.4M417.9M383.1M454.5M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities402M642.4M409.3M517.4M(34.8M)
Total Non-current Liabilities7.31B6.96B5.61B6.98B6.93B
Total Liabilities10.09B10.04B8.83B10.31B9.76B
Common Stock8.5M8.1M7.7M7.6M7.5M
Retained Earnings10.46B10.58B7.89B8.3B8.64B
Accumulated OCI(192M)(493.2M)(59.3M)(261.6M)(27.6M)
Other Stockholders Equity00000
Minority Interest20.6M18.9M15.5M14.3M16.9M
Total Equity10.29B10.12B7.89B8.07B8.64B
Total Debt6.34B6.25B5.95B7.27B7.2B
Net Debt4.87B5.93B5.42B5.75B6.67B

Labcorp Holdings Inc.

NYSE:LH

Intrinsic Alpha fair value

Locked

Current Price

$370.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.